BACKGROUND: Disturbances in emotion regulation are the hallmarks of major depressive disorder (MDD). The incapacity to control negative emotion in patients has been associated with abnormal hyperactivation of the limbic system and hypoactivation of the frontal cortex. The amygdala and orbital frontal cortex (OFC) are two critical regions of the emotion regulation neural systems. METHODS: This study investigated the anatomical basis of abnormal emotion regulation by tracking the fiber tracts connecting the amygdala and OFC. In addition, using dynamic casual modeling on resting-state fMRI data of 20 MDD patients and equivalent controls, we investigated the exact neural mechanism through which abnormal communications between these two nodes were mediated in MDD. KEY RESULTS: The results revealed disrupted white matter integrity of fiber tracts in MDD, suggesting that functional abnormalities were accompanied by underlying anatomical basis. We also detected a failure of inhibition of the OFC on the activity of the amygdala in MDD, suggesting dysconnectivity was mediated through "top-down" influences from the frontal cortex to the amygdala. Following 8 weeks of antidepressant treatment, the patients showed significant clinical improvement and normalization of the abnormal OFC-amygdala structural and effective connectivity in the left hemisphere. CONCLUSIONS & INFERENCES: Our findings suggest that pathways connecting these two nodes may be core targets of the antidepressant treatment. In particular, it raised the intriguing question: Does the reversal of structural markers of connectivity reflect a response to antidepressant medication or activity-dependent myelination following a therapeutic restoration of effective connectivity?
BACKGROUND: Disturbances in emotion regulation are the hallmarks of major depressive disorder (MDD). The incapacity to control negative emotion in patients has been associated with abnormal hyperactivation of the limbic system and hypoactivation of the frontal cortex. The amygdala and orbital frontal cortex (OFC) are two critical regions of the emotion regulation neural systems. METHODS: This study investigated the anatomical basis of abnormal emotion regulation by tracking the fiber tracts connecting the amygdala and OFC. In addition, using dynamic casual modeling on resting-state fMRI data of 20 MDDpatients and equivalent controls, we investigated the exact neural mechanism through which abnormal communications between these two nodes were mediated in MDD. KEY RESULTS: The results revealed disrupted white matter integrity of fiber tracts in MDD, suggesting that functional abnormalities were accompanied by underlying anatomical basis. We also detected a failure of inhibition of the OFC on the activity of the amygdala in MDD, suggesting dysconnectivity was mediated through "top-down" influences from the frontal cortex to the amygdala. Following 8 weeks of antidepressant treatment, the patients showed significant clinical improvement and normalization of the abnormal OFC-amygdala structural and effective connectivity in the left hemisphere. CONCLUSIONS & INFERENCES: Our findings suggest that pathways connecting these two nodes may be core targets of the antidepressant treatment. In particular, it raised the intriguing question: Does the reversal of structural markers of connectivity reflect a response to antidepressant medication or activity-dependent myelination following a therapeutic restoration of effective connectivity?
Authors: Jonathan A D Farrell; Bennett A Landman; Craig K Jones; Seth A Smith; Jerry L Prince; Peter C M van Zijl; Susumu Mori Journal: J Magn Reson Imaging Date: 2007-09 Impact factor: 4.813
Authors: Christina L Fales; Deanna M Barch; Melissa M Rundle; Mark A Mintun; Jose Mathews; Abraham Z Snyder; Yvette I Sheline Journal: J Affect Disord Date: 2008-06-17 Impact factor: 4.839
Authors: Paul J Thomas; Srinivas Panchamukhi; Joshua Nathan; Jennifer Francis; Scott Langenecker; Stephanie Gorka; Alex Leow; Heide Klumpp; K Luan Phan; Olusola A Ajilore Journal: Psychiatry Res Neuroimaging Date: 2020-03-05 Impact factor: 2.376
Authors: Allison C Nugent; Cristan Farmer; Jennifer W Evans; Sam L Snider; Dipavo Banerjee; Carlos A Zarate Journal: Hum Brain Mapp Date: 2019-06-09 Impact factor: 5.038
Authors: Negar Fani; Tricia Z King; Cherita Clendinen; Raven A Hardy; Sindhuja Surapaneni; James R Blair; Stuart F White; Abigail Powers; Tim D Ely; Tanja Jovanovic; Kerry J Ressler; Bekh Bradley Journal: J Affect Disord Date: 2019-04-30 Impact factor: 4.839
Authors: Kristina L Bell; Juliann B Purcell; Nathaniel G Harnett; Adam M Goodman; Sylvie Mrug; Mark A Schuster; Marc N Elliott; Susan Tortolero Emery; David C Knight Journal: Neuroscience Date: 2021-05-15 Impact factor: 3.708
Authors: Peter Karel; Annette Van der Toorn; Louk Vanderschuren; Chao Guo; Mina Sadighi Alvandi; Liesbeth Reneman; Rick Dijkhuizen; Michel M M Verheij; Judith R Homberg Journal: Addict Biol Date: 2019-02-12 Impact factor: 4.280
Authors: Lamya'a M Dawud; Esteban C Loetz; Brian Lloyd; Rachel Beam; Simon Tran; Kim Cowie; Kim Browne; Tassawwar Khan; Richard Montoya; Benjamin N Greenwood; Sondra T Bland Journal: Dev Psychobiol Date: 2020-06-10 Impact factor: 3.038